Journey Medical (DERM) Stock Price, Quote, News & History | Benzinga

Journey Medical Corp (DERM) Stock Price, Quote, News & History

DERMNASDAQ

Trade with Public

Trade with Public

$5.07

0.071.40%

At close: May 8, 5:00 PM EST

$5.07

N/A

After Hours: May 8, 4:01 PM EST

Earnings: Q1 2026 Earnings in 3 days from now on Wed May 13th, after the market close

Conference Call: Conference call scheduled in 3 days at 4:30 PM

Click to view the webcast

OverviewNews Earnings Options Analyst Ratings Short Interest Stock Report

Key Statistics

Open

$4.98

Close

$5.07

Volume / Avg.

100.65K / 213.51K

Day Range

$4.84 - $5.10

52 Wk Range

4.31 - 9.56

Market Cap

$138.57M

P/E Ratio

-

Dividend Yield

-

Exchange

NASDAQ

RSI

42

Short Interest

23.34%

Days to Cover

18.57

Recent Journey Medical Corp News

What's Going On With Journey Medical Stock Today?

Journey Medical (NASDAQ:DERM) shares are trading higher Monday after the company announced the U.S. Food and Drug Administration approved its Emrosi drug for the treatment of rosacea.

Adam Eckert

Why Skye Bioscience Shares Are Trading Lower By 19%? Here Are Other Stocks Moving In Monday's Mid-Day Session

Avi Kapoor

Why Westport Fuel Systems Shares Are Trading Lower By Around 10%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session

Shares of Westport Fuel Systems Inc. (NASDAQ: WPRT) fell sharply during Tuesday’s session after posting a wider-than-expected fourth-quarter loss. Westport Fuel Systems posted a quarter loss of 81 cents per share, compared to market expectations for a loss of 51 cents per share.

Avi Kapoor

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Cash Flows

Operating Cash Flow (TTM)

-12.44M

Investing Cash Flow (TTM)

0

Financing Cash Flow (TTM)

16.23M

Free Cash Flow (TTM)

-12.44M

Capital Expenditure (TTM)

-

Net Change in Cash (TTM)

3.79M

Analyst Trends and Forecast

1

Mar

Buy

Hold

Sell

Strong Sell

Analyst Rating and Forecast

4.0

Buy

Strong Buy

Buy

Hold

Sell

Strong Sell

Valuation Metrics

Enterprise Value

$139.95M

PE Ratio (TTM)

-

PE Ratio (FWD)

166.67

PEG Ratio (TTM)

-

PS Ratio (TTM)

1.98

PB Ratio (TTM)

4.29

Earnings Yield % (TTM)

-9.41%

Earnings Yield % (FWD)

0.60%

EV / EBITDA (TTM)

-

Price / EBITDA (TTM)

-

Price / Free Cash Flow (TTM)

-

Book Value / Share

$1.16

Company Debt

Total Debt

$25.28M

LT Debt

$25.28M

LT Debt Issuance (TTM)

$16.36M

LT Debt Repayment (TTM)

-$625.00K

Total Cash

$24.09M

Debt to Equity

0.80

Issuance of Debt (TTM)

$15.73M

Repayment of Debt (TTM)

-$625.00K

Key Statistics

Open

$4.98

Close

$5.07

Volume / Avg.

100.65K / 213.51K

Day Range

$4.84 - $5.10

52 Wk Range

4.31 - 9.56

Market Cap

$138.57M

P/E Ratio

-

Dividend Yield

-

Exchange

NASDAQ

RSI

42

Short Interest

23.34%

Days to Cover

18.57

About

Sector

Health Care

Industry

Pharmaceuticals

Journey Medical Corp is a commercial-stage pharmaceutical company that focuses on the selling and marketing of U.S. Food and Drug Administration (FDA) approved prescription pharmaceutical products for the treatment of dermatological conditions. Its c...

Show More

Edge Rankings

Stock Score Locked: Want to See it?

Benzinga Rankings give you vital metrics on any stock – anytime.

Reveal Full Score

Compare

EPS worse than industry

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

EPS worse than industry

FAQ

Q

How do I buy Journey Medical (DERM) stock?

A

You can purchase shares of Journey Medical (NASDAQ:DERM) through any online brokerage.

View our list of the best stock brokerages

Q

Who are Journey Medical (DERM) competitors?

A

Other companies in Journey Medical’s space includes: MediWound Ltd (NASDAQ:MDWD), SCYNEXIS Inc (NASDAQ:SCYX), Aardvark Therapeutics Inc (NASDAQ:AARD), Rani Therapeutics Holdings Inc (NASDAQ:RANI) and Incannex Healthcare Inc (NASDAQ:IXHL).

Q

What is the forecast, or price target, for Journey Medical (DERM) stock?

A

Journey Medical has a consensus price target of $11.08.

Q

What is the current price for Journey Medical (DERM)?

A

The stock price for Journey Medical (NASDAQ: DERM) is $5.07 last updated May 8, 2026 at 4:01 PM EDT.

Q

Does Journey Medical (DERM) pay a dividend?

A

There are no upcoming dividends for Journey Medical.

Q

When is Journey Medical (NASDAQ:DERM) reporting earnings?

A

Journey Medical does not have any upcoming earnings scheduled.

Q

Is Journey Medical (DERM) going to split?

A

There is no upcoming split for Journey Medical.

Q

What sector and industry does Journey Medical (DERM) operate in?

A

Journey Medical is in the Health Care sector and Pharmaceuticals industry. They are listed on the NASDAQ.

People Also Watch

No data available

No data available

Aardvark Therapeutics Inc

No data available

Rani Therapeutics Holdings Inc

No data available

Incannex Healthcare Inc

No data available

Telomir Pharmaceuticals Inc

No data available

No data available

No data available